TrialAllergy2025
Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary Angioedema.
Marc A Riedl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it
TrialAllergy2025
Marc A Riedl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.